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Selection for Immune Responses 
to Porcine Circovirus (PCV2) to Decrease 
Incidence of Porcine Circovirus Associated Disease 
(PCVAD)
Selection for 65-day weight along with PCV2 viremia and antibody titers offers great potential to decrease inci-
dence of PCVAD.
Jared S. Bates
Roman Moreno
Alan R. Doster
Rodger K. Johnson1
Summary
Genetic and environmental effects 
on incidence of Porcine Circovirus 
Associated Disease (PCVAD) and 
immune responses to Porcine Circovi-
rus 2 (PCV2), and their relationships 
with body weights were studied in 3,440 
pigs of the Nebraska litter size selec-
tion lines. Pigs were weighed at birth, 
weaning, 65, and 180 days of age and 
scored for symptoms of PCVAD every 
10 days from 70 to 180 days of age. 
Necropsies were performed to confi rm 
accuracy of scoring. PCV2 viremia, and 
anti bodies to PCV2, Porcine Reproduc-
tive and Respiratory Syndrome Virus, 
Myco plasma hyopneumoniae and 
Actino bacillus pleuropneumoniae were 
measured in serum from blood samples 
drawn at various ages from live pigs 
and in tissues of pigs necropsied. PCV2b 
genotype was confi rmed to be the patho-
gen causing PCVAD; other pathogens 
studied were not involved. Pigs with no 
symptoms of PCVAD had signifi cantly 
greater weights (0.22, 1.12, 6.6, and 46.0 
lb, at birth, weaning, 60 d, and 180 d, 
respectively) than affected pigs. Herita-
bility of PCVAD score was 16% + 4%. 
The location in which pigs were raised 
accounted for 22% of the variation 
in PCVAD score. Nearly all pigs were 
non-viremic until 90 days of age, but 
many had antibody titers at weaning 
and at 60 days of age. These maternal 
antibodies appeared to protect pigs from 
PCVAD until approximately 90 days 
of age. Heritability of viremia level at 
90 days of age was greater than at 125 
days of age (38 + 11% vs 11 + 8%). 
Genetic variation existed for antibody 
titers at 90 (h2 = 55 + 21%) and 125 
days of age (h2 = 10 + 8%). Incidence 
of PCVAD was correlated genetically 
with body weights, PCV2 viremia level, 
PCV2 antibody titers, and body weights. 
Expected response to direct selection 
for reduced PCVAD score was very low 
(-0.89% in one generation), whereas 
expected response to index selection for 
65-day weight and PCV2 viremia and 
antibody titers at 90 days of age was 
-8.0%, 998% greater than direct selec-
tion. Genomic selection for decreased 
incidence of PCVAD is feasible.
Introduction
Porcine Circovirus Associated 
Disease (PCVAD), caused by Porcine 
Circovirus 2 (PCV2), causes high 
economic losses to pork producers. 
Symptoms of PCVAD in the University 
of Nebraska–Lincoln swine research 
herd were fi rst observed in 2002. Not 
all pigs on the farm were infected and 
the incidence rate varied depend-
ing on the genetic makeup of the 
pigs, their location at the farm, and 
season of the year. The incidence rate 
in crossbred pigs was very low, but a 
signifi cant number of pigs of the UNL 
lines selected for increased litter size 
were affected. Some pigs seemed to be 
highly sensitive to the disease whereas 
others in the same pen remained 
healthy and showed no symptoms. 
Usually, only one or two pigs in a pen 
were affected, but it was common for 
a high percentage of pigs within some 
litters to be affected, even when raised 
in different locations.
These observations pointed to 
underlying genetic variation in the 
immune response of pigs to the PCV2 
virus. A study of PCVAD conducted 
at another institution supports this 
hypothesis as the incidence rate was 
greater in some breed crosses than 
others. However, sample size in that 
experiment was too small to determine 
the degree of genetic variation (herita-
bility) in incidence rate of PCVAD and 
in immune responses to PCV2 virus. 
If suffi cient genetic variation exists, 
then greater resistance to PCV2 and 
reduced incidence of PCVAD through 
selection are possible. When practiced 
in nucleus breeding populations, 
greater resistance achieved through 
selection can be transmitted through 
the breeding pyramid to commercial 
producers, possibly reducing the need 
for vaccination.
We therefore conducted a study in 
which pigs were systematically scored 
for PCVAD, weighed and bled to cre-
ate a database for genetic analyses. 
Because secondary pathogens are often 
thought to be involved in expression 
of PCVAD, pigs were also character-
ized for Porcine Reproductive and 
Respiratory Syndrome Virus (PRRVS), 
Mycoplasma hyopneumoniae and 
Actinobacillus pleuropneumoniae to 
determine whether these pathogens 
were involved along with PCV2 in 
expression of PCVAD.
(Continued on next page)
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Population
Pigs were from generations 24 
to 26 of UNL selection lines, Lines 
2 and 45, and control lines, Lines 16 
and 61, that were derived from a Large 
White-Landrace composite population 
formed in 1979. Lines 2 and 45 have 
been selected for increased litter size 
(generations 1 to 20) and increased 
litter size, increased growth, and 
decreased backfat, generations 21 to 
27. Lines 16 and 61 were randomly 
selected . Each line is maintained with 
40 to 45 litters per generation. Line 2 
and 16 litters were born in July and 
August (denoted contemporary group 
1, CG1) and Line 45 and 61 litters were 
born in January and February (CG2).
Pig Management, PCVAD Scoring, and 
Serum Sampling
Within two days of farrowing, fos-
tering of pigs among sows both within 
and between lines was practiced. 
Fostering could not be accomplished 
uniformly in all litters. Total number 
and number of live pigs per litter, pig 
birth (n = 3,440) and weaning weights 
(n = 3,438), and number after foster 
and weaned per foster dam (NW) were 
recorded. 
Pigs were weaned at approxi-
mately 17 days and grouped by age 
in nursery pens of 30 pigs per pen. 
At 60-65 days of age, four boars from 
each of the 15 largest litters and four to 
five females from each of the largest 20 
litters in Lines 2 and 45 were identified 
as candidates for selection as breeders. 
Two sons per sire and one to two gilts 
per litter were randomly selected as 
candidates for breeding in Lines 16 
and 61. Final selections occurred at 
180 days of age. 
All breeder candidates were placed 
in one of six rooms, eight pens per 
room and 10 pigs per pen, in a con-
fined, mechanically ventilated building 
denoted as Location 1. Remaining pigs 
were placed in one of three locations. 
Location 2 was a confined building, 25 
pens of 10 pigs per pen, with natural 
ventilation regulated by thermostati-
cally controlled curtains over windows. 
Location 3 was a confined building, 23 
pens of 10 pigs per pen, with natural 
ventilation controlled manually by 
adjusting doors over windows. Loca-
tion 4 was five outdoor lots containing 
a small hoop structure with straw 
bedding. There were 50 to 60 pigs per 
lot. Pigs in CG1 were in Locations 1, 2, 
and 3; pigs in CG2 were in Locations 
1, 2, and 4. 
Pigs with symptoms of PCVAD 
were first observed in 2002 (generation 
21). Observations in subsequent years 
led us to a protocol that produced 
data for genetic analyses. During 
Generations 24, 25, and 26 pigs were 
systematically weighed, scored for 
PCVAD, and blood samples were 
drawn. Weight at 65 days was recorded 
for 2,646 pigs (some pigs were not 
weighed) when they were placed in 
finishing pens and weight at 180 days 
(n = 3,115) were recorded. Beginning 7 
days after pigs were placed in finishing 
pens, they were scored for symptoms 
of PCVAD once every 7 to 10 days, 
approximately 10 scores per pig, until 
180-day weight was recorded. Pigs 
with no symptoms received a score of 
0, pig with minor symptoms a score of 
1, and pigs with definitive symptoms 
a score of 2. Scores were based on 
degrees of muscle wasting, growth 
retardation, rough hair coat, diarrhea, 
and respiratory distress. A score of 1 
was used only to identify pigs for more 
careful future observation. Only pigs 
receiving one or more score of 2 were 
considered positive for PCVAD. 
Blood was collected at 60, 90, and 
125 days of age from all pigs from Gen-
eration 25, CG2, and Generation 26, 
CGs 1 and 2. Blood was collected from 
pigs at weaning in Generation 25, CG2 
and from sows in Generation 26, CG1 
when their pigs were weaned. PCV2 
viremia, a measure of the pigs ability to 
replicate virus, was measured in serum 
of all pigs with PCVAD score of 2, in 
serum from a randomly selected pen 
mate with scores of only 0, in samples 
of a full sib from another pen, and in 
samples from two pigs drawn randomly 
from each birth litter in which no pigs 
were positive for PCVAD. Serum was 
sent to Iowa State University Veterinary 
Diagnostic Laboratory, Ames, Iowa, 
where Porcine Circovirus II C-ELISA 
PCR and PCV2 Quantitation (qPCR) 
were performed to obtain PCV2 vire-
mia and antibody levels.
 ELISA was used to test sub-
samples of serum for Mycoplasma 
hyopneumoniae (MH), Actinobacillus 
pleuropneumoniae (APP), and Porcine 
Reproductive and Respiratory Virus 
(PRRSV). Samples collected at 90 (n = 
261) and 125 days (n = 228) from pigs 
from generation 25, CG2, were tested 
for MH; samples collected at 125 days 
of age from generation 25, CG2 (n 
= 228) and Generation 26, CG1 and 
CG2 (n = 511) were tested for APP. 
The UNL swine herd is free of PRRSV. 
To confirm this status, serum from 
52 pigs from generations 24 to 26 was 
tested for PRRSV.
Necropsies were performed on 
samples of pigs with a PCVAD score 
of 2 from generation 24, CG1 (n = 
10) and CG2 (n = 11), and generation 
25, CG2 (n = 17) and in 11 randomly 
selected pigs with PCVAD score of 0 
from generation 25, CG2. Pigs were 
from all locations and only one pig 
from any one litter was selected for 
necropsy. Immunohistochemistry and 
RT-PCR for PCV2 were performed in 
lung, cervical lymph node, mesenteric 
lymph node, tonsil, kidney, and ileum 
of these pigs. Nasal swabs for RT-PCR 
testing were collected from five pigs; 
two of these pigs had no lesions sug-
gestive of PCVAD. Necropsies and 
RT-PCR were done at the Veterinary 
Diagnostic Center of the University of 
Nebraska Department of Veterinary 
and Biomedical Sciences. These pigs 
were also tested for PRRSV antibodies 
by ELISA. Serum from three pigs that 
were necropsied and that were diag-
nosed with PCVAD were submitted to 
the Veterinary Diagnostic Laboratory 
at Iowa State University, Ames, Iowa 
where Porcine Circovirus II C-ELISA 
PCR-PCV2 Quantitation in which the 
virus was sequenced to determine the 
specific PCV2 transcript in this herd.
Statistical Procedures
Data were analyzed with proce-
dures appropriate for genetic analyses. 
Two traits had binomial distributions 
as the outcome was either yes or no, 
coded as 0 or 1. These were PCVAD 
score (1 = positive, 0 = negative) and 
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whether a pig was viremic (0 = no 
viral replication, 1 = viral replication, 
veremia level greater than 0). For those 
pigs that were viremic (coded score 
of 1) the observed viremia (genomic 
copies per ml) were expressed as log10 
to normalize the distribution. PCV2 
antibody titers and body weights were 
normally distributed. 
Table 1 contains a description of 
traits and numbers of records. Table 2 
contains the joint distributions of PC-
VAD scores, PCV2 viremia, and PCV2 
antibody titers. Genetic analyses used a 
pedigree fi le containing 12,032 pigs, all 
those with phenotypes in the present 
study and all parent animals tracing 
back to the base generation. Traits ana-
lyzed were PCVAD Score, birth weight, 
weaning weight, 65-day weight, 180-day 
weight, viremia scores at 90 days and 
125 of age (the 0 or 1 code), log10 of 
viremia level at 90 days and 125 days of 
age in pigs with positive viremia scores, 
and PCV2 antibody titers at 60, 90, and 
125 days of age. Antibody titers .5 and 
greater are considered to be positive, 
evidence that the pig had been exposed 
to virus, titers of .2 to .49 are in the 
suspect range, and those below .2 are 
considered to be negative. 
Results
Observations and Fixed Effects
Overall, 14.4% of pigs had at least 
one positive PCVAD score, but the 
incidence varied greatly across genera-
tions (Figure 1). Mortality rate of pigs 
with positive score was 35.4%. Genetic 
lines did not differ signifi cantly in inci-
dence of PCVAD.
Nearly all serum samples collected 
at 60 days of age (94.6 %) were nega-
tive for PCV2 viremia; therefore vire-
mia at 60 days of age was not analyzed. 
All but two serum samples collected at 
90 days of age from pigs in generation 
26, CG2 had negative viremia (Table 
2); therefore, data from that group 
were deleted from analyses of 90-day 
viremia level. All but two serum sam-
ples collected from weaned pigs were 
negative for PCV2 viremia, but 37 
of 77 of their dams were positive. 
Average antibody titers for sows and 
Table 1. Number of observations for each trait by generation and contemporary group.
 Generation Group2   Trait1
   BWT WWT W65 W180 PCVAD score
 24 1 669 669 — 659 669
 24 2 649 649 543 622 649
 25 1 281 281 281 262 281
 25 2 511 510 510 431 511
 26 1 629 629 624 507 629
 26 2 701 698 688 634 701
   Vsows VW V60 V90 V125
 25 2 — 279 287 261 228
 26 1   77 — 292 294 244
 26 2 — — — 217 211
   IgGsows IgGWIg G60Ig G90Ig G125
 25 2 — 280 287 271 229
 26 1   75 — 301 294 244
 26 2 — — 211 217 210
1BWT = birth weight; WWT = weaning weight; W65 = weight at 65 d; W180 = weight at 180 d; Vsows 
= sow viremia at weaning; VW = pig viremia at weaning; V60, IgG60, V90, IGg90, V125 and IgG125 = 
PCV2 viermia and antibody, respectively, at 60, 90, and 125 days of age.
2Group1 = Lines 45 and 61 (CG2, winter litters), Group 2 = lines 1 and 2 (CG1, summer litters).
Table 2. Distribution of pigs with combinations of PCVAD score, virema, and IgG levels at days 90 
and 125 days within generation (G) and contemporary group (CG) and overall.
 PCVAD score1 Viremic2 IgG3 G25CG1 G26CG1 G26CG2Total
Day 90
1 + + 11 16 0 27
1 + S 48 64 0 112
1 + - 27 44 0 71
1 - + 4 4 14 22
1 - S 11 3 8 22
1 - - 7 0 3 10
0 + + 36 59 1 96
0 + S 55 68 0 123
0 + - 18 21 1 40
0 - + 15 10 103 128
0 - S 19 5 57 81
0 - - 11 0 30 41
Day 125
1 + + 59 80 9 148
1 + S 8 3 3 14
1 + - 3 0 0 3
1 - + 12 2 0 14
1 - S 1 0 1 2
1 - - 0 0 4 4
0 + + 104 145 78 327
0 + S 12 3 17 32
0 + - 0 0 12 12
0 - + 29 11 13 53
0 - S 0 0 19 19
0 - - 0 0 55 55
10 = negative and 1 = positive score for PCVAD.
2+ indicates PCV2 viremia level > 0, - indicates PCV2 viremia = 0.
3+ = IgG titer ≥ 0.5, S = 0.2 < titer < 0.5, - = titer < 0.2.
(Continued on next page)
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progeny were 1.07 + 0.15 and  
0.90 + 0.16, respectively. 
Antibody titers for PCV2 at 60, 
90, and 125 days of age for each con-
temporary group are shown in Figure 
2. Titers at 60 and 90 days were similar 
in generation 25, CG2, and generation 
26, CG1, greatest in Generation 26. 
Frequency of viremic pigs varied 
greatly across generations, contem-
porary groups, and ages (Figure 3). In 
generation 26, CG2, 53.9% of the pigs 
were non-viremic at 90 days of age 
but had antibody titers greater than 
0.5 (Table 2). Only 5.9% of the pigs in 
other groups were non-viremic and had 
high antibody titers. Non-viremic pigs 
at 125 days of age with antibody titers 
less than 0.2 occurred in 60.8% of pigs 
from generation 26 CG2, but in only 
10.2% of the pigs in the other groups. 
Incidence of PCVAD was greater 
in males than females and males had 
greater (P < 0.05) PCV2 antibody 
titers at 60 (0.03) and 90 days (0.05). 
The probability of being viremic at 90 
days of age was less for females than 
males (-0.30, P < 0.05).
Pigs with 0 PCVAD score weighed 
more (P < 0.0001) at birth, weaning, 
65 d, and 180 days (0.22, 1.12, 6.6, and 
46.0 lb, respectively) than pigs with 
score of 1. They also had lower PCV2 
viremia levels at 90 (0.26 +0.15) and 
125 days (0.85 + 0.12) and greater 
antibody titers (0.04 + 0.01 and  
0.05 + 0.02, respectively).
PCV2 Sequence
All three pigs whose PCV2 
mRNA was sequenced were positive 
for PCV2b genotype. The sequence 
for one pig was 100% identical to a 
PCV2 isolate previously characterized 
and described in the National Center 
for Biotechnology Information data-
base. The sequences for the other two 
pigs were not 100% identical to any 
sequence in the database. One of them 
had a single base change at position 
116 (G to A); the other one had two 
base changes, one at position 116 (G 
to A) and one at position 465 (C to G). 
These findings confirm that PCV2b 
was the causative virus for PCVAD in 
this population but that mutations 
Figure 1. Percentage of pigs scored positive for PCVAD.
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Figure 2. Mean PCV2 antibody titers.
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Figure 3. Viremic pigs, %, at 90 and 125 days.
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had occurred causing slightly different 
nucleotide sequences from those pre-
viously characterized. 
Necropsy Findings.
Tissue samples from 36 of the 
38 pigs that were positive for PCVAD 
were also positive for PCV2. Tis-
sues of the other two were negative, 
but their nasal swabs were positive. 
Tissues from all 11 pigs scored as 
negative for PCVAD were negative for 
PCV2. Pigs with PCVAD had severe 
wasting, weight loss, rough hair coat, 
enlarged mesenteric lymph nodes, 
lesions indicative of pneumonia, and 
chronic colitis. Lymphocyte deple-
tion within mesenteric lymph nodes 
and giant cells in lymphoid follicles, 
splenic follicles , and Peyer’s Patches, 
and thymic atrophy due to lymphocyte 
depletion were observed. Nineteen 
pigs had symptoms of Mycoplasma 
hyopneumoniae; 18 had symptoms of 
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(Continued on next page)
Genetic and Environmental Parameters
Percentages of total variation due 
to genetic and environmental effects 
for PCVAD score and body weights 
are in Table 3 and those for PCV2 
viremia and antibody titers are in 
Table 4. Direct heritability, a measure 
of the relative importance of genes 
of the pig, of PCVAD score was 16 
+ 4%. Heritabilities of body weights 
ranged from 16% for weaning weight 
to 27% for birth weight. Genes of 
the dam, maternal heritability, were 
important for birth and 180-day 
weights. The location in which pigs 
were raised accounted for the most 
variation (22%) in PCVAD score 
whereas several environmental sources 
of variation contributed to variation 
in body weights. For pigs with positive 
viremia score (levels greater than zero), 
heritability estimate of viremia level at 
90 days of age was greater than at 125 
days of age (38 + 11% vs 11 + 8%). 
Genetic variation existed for antibody 
titers at 125 days of age (h2 = 10 + 
8%), but not at 90 days of age when 
all data were included in analyses. 
However, when data for generation 26, 
CG2 were deleted, genetic variation 
in PCV2 antibody titer at 90 days of 
age was high (h2 = 55 + 21%). A large 
percentage of the variation in viremia 
score at 90 and 125 days of age was due 
to either the location or the room in 
which pigs were raised. These sources 
of variation were relatively small for 
viremia level and antibody titers. 
Genetic and residual correlations 
among traits were calculated but are 
not presented here. The important 
ones were that PCVAD score was quite 
highly correlated genetically with day 
90 viremia (rg = 0.75) and antibody 
level (rg = -0.67) and moderately cor-
related with 65-day weight (rg = -0.53). 
Neither birth weight nor weaning 
weight were signifi cantly correlated 
genetically with viremia or antibody 
levels. However, weaning weight was 
highly correlated genetically with vire-
mia at 125 days of age (rg = -0.73) and 
180-day weight was negatively corre-
lated with viremia at both 90 and 125 
days of age and positively correlated 
with antibody titers at 90 days of age. 
Viremia level at 90 and 125 days of age 
were positively correlated genetically 
(rg = 0.59) and viremia and antibody 
titers at 90 days of age were negatively 
correlated (rg = -0.51). Antibody titers 
at 90 and 125 days of age were posi-
tively correlated (rg = 0.59).
Although several environmental 
correlations among traits were signifi -
cant, none were especially strong. Most 
notable were that environmental effects 
on score for PCVAD and for body 
weights through 65 days of age were 
correlated (-0.47 < re < -0.39), environ-
mental effects on viremia and antibody 
levels at 90 days of age were correlated 
(re = -0.38), and viremia at 90 days of 
age was negatively correlated with body 
weights (-0.26 < re < -0.16).
Discussion
We conclude from this study and 
others in the literature that genetic 
variation in incidence of PCVAD 
Table 3. Percentage of variation in PCVAD score and body weights due to different sources.
 PCVAD
Source1 score BWT, lb WWT, lb 65-day wt, lb 180-day wt, lb
  Genetic effects
Pigs genes (hd
2) 16.0+ 4.0 26.7 +7.0 16.0 +6.0 23.0 + 6.02 3.0 + 6.0
Dam’s genes (hm
2)  18.3   11.0
  Environmental effects
Birth litter 10.0 11.0
Weaning litter 27.5 12.0
Contemporary group 11.2 1.0 0.2 8.0 7.0
Location 22.0 3.0
Pen 5.1 5.0
Residual 47.2 43.3 57.1 47.0 51.0
Phenotypic standard 
deviation 1.46 0.11 0.43 1.97 6.4
1hd
2 = direct heritability, hm
2
 = maternal heritability (+ standard error of estimate of hd
2).
Table 4. Percentage of variance of PCV2 viremia score1, vermia level2, and antibody titers3 at 90 and 
125 days of age.1
Parameter4 VS90 VS125 Viremia90 Viremia125 IgG90 IgG902 IgG125
Pigs genes (hd
2)   38 + 11 11 + 8  55 + 21 10 + 8
Birth litter 5.0 4.9   33.3 7.5 5.6
Contemporary group 77.0   18.0 16.7  18.9
Location 2.0 24.0  2.1   33.3
Room  26.2 1.9    6.7
Residual 15.0 44.9 60.2 68.4 50.0 37.5 25.6
σp
2 2.57 1.50 1.5 0.97 0.24 0.2 0.3
1VS90 and VS125 = viremia score (positive vs 0).
2Viremia90 and Viremia125 = log10 (PCV2 genomic copies/mL) for pigs with positive scores.3IgG90 and IgG125 = PCV2 antibody titer.
2Generation 26, CG2 data deleted.
4hd
2 = direct heritability + standard error. 
Streptococcus suis, and four had symp-
toms of Lawsonia intracellularis. 
ELISA Screening
All serum samples tested for 
PRRSV and for Mycoplasma hyopneu-
moniae were negative. Thirty two of 
the 228 serum samples collected at 125 
days of age from generation 25, CG2 
pigs were positive for APP. Twenty one 
of 513 serum samples collected at 90 
days of age from pigs of generation 26 
were positive for APP, 16 had titers in 
the suspect range, and the rest were 
negative. Eight pigs that were posi-
tive for APP and fi ve with titers in the 
suspect range had positive PCVAD 
scores. However, 142 pigs with posi-
tive PCVAD scores were negative for 
APP. Thus, PRRSV and Mycoplasma 
hyopneumoniae can be ruled out as 
secondary pathogens, and APP was not 
likely a secondary pathogen, involved 
in expression of PCVAD in this popula-
tion.
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and measures of immune responses 
to PCV2 exists. The heritability of 
PCVAD score was 16% and heritabili-
ties of PCV2 viremia and antibody 
levels at 90 days of age were 38% and 
55%, respectively. Genetic variation 
in viremia and antibody levels at 125 
days of age were less and were not sig-
nifi cant, perhaps because death of pigs 
with PCVAD between 90 and 125 days 
resulted in fewer records and decreased 
the genetic variance in remaining pigs.
Viremia and antibody levels at 90 
days of age and 65-day weight were 
quite highly correlated genetically with 
PCVAD score. Thus selection for these 
traits may be an effective way to de-
crease incidence of PCVAD. Expected 
selection responses were calculated 
for different selection strategies. These 
were 1) direct selection — selection of 
breeders only from pigs that never dis-
played symptoms of PCVAD, 2) single-
trait selection for weight, viremia, or 
antibody levels, and 3) index selection 
for correlated traits or PCVAD score 
plus correlated traits. 
Even though PCVAD score is 
heritable, direct selection was relatively 
ineffective, resulting in a reduction 
of incidence of PCVAD of only -.8% 
in the fi rst generation. This result oc-
curred because 85% of the pigs, those 
with score of 0, were candidates for 
selection, resulting in a very low selec-
tion rate. The other traits are continu-
ously distributed so pigs vary across 
the entire range of the distribution. 
Assuming 10% of the males and 30% 
of the females are selected for high 
PCV2 antibody titers at 90 days result-
ed in the greatest correlated expected 
response to single-trait selection (gen-
eration 1 response = -6.5%). Greatest 
expected response was for a three-trait 
index including 65-day weight and 
PCV2 viremia and antibody titers at 
90 days of age (-8.0%). A four-trait 
index of these traits and PCVAD score 
produced the same expected response 
per generation. Expected selection 
responses were 414 to 998% greater 
when correlated traits were used than 
from direct selection. 
Necropsy results confi rmed that 
PCV2 was the main causative agent 
of PCVAD in this population. Geno-
typing PCV2 revealed that PCV2b was 
likely the causative agent. However, at 
least three allelic forms, and possibly 
more, existed. Thus, mutations have 
occurred in the PCV2b genome, but 
the consequence is not known. 
Porcine Reproductive and 
Respiratory Virus, Mycoplasma 
hyopneumoniae, and Actinobacillus 
pleuropneumoniae were not secondary 
pathogens involved in expression of 
PCVAD. In other work, co-infection 
of pigs with PCV2 and Gram-negative 
bacteria induced viral replication of 
PCV2. Diagnostics for these pathogens 
were not performed, but infection of 
pigs with pathogens such as Escheri-
chia coli and Haemophilus infl uenzae, 
Gram-negative bacteria known to be 
present in this population, may have 
increased the risk of PCVAD. 
A strong relationship between 
PCV2 viremia level at 90 days of age 
and incidence of PCVAD across con-
temporary groups existed. Incidence 
of positive PCVAD Scores was 3.9% 
in generation 26, CG2, and only 1% 
of these pigs were viremic at 90 days 
of age. The incidences of PCVAD in 
generation 25, CG2, and Generation 
26, CG1, were greater than 20%; 75% 
and 93% of the pigs in these respective 
groups were viremic. 
Pigs with PCVAD differed in birth 
weight, weaning weight, 65-day weight, 
and 180-day weight, even though some 
of these weights were recorded well 
before pigs expressed symptoms of 
PCVAD. The genetic correlations of 
PCVAD score with birth and weaning 
weights were positive, but not signifi -
cant. However, environmental correla-
tions were negative and signifi cant, 
indicating that the phenotypic rela-
tionship was largely due to environ-
mental effects that reduced early body 
weights and increased risk of PCVAD. 
Mean PCV2 antibody titers in pigs 
at weaning was high, most likely due to 
maternal PCV2 antibodies because all 
these pigs were non-viremic. Antibody 
titers decreased from weaning to 60 
days of age, but 94.6% of pigs were 
still non-viremic at 60 days of age. 
Antibody titers continued to decrease 
from 60 to 90 days of age, suggest-
ing that maternal antibodies were 
deteriorating . Effects associated with 
the birth litter were a major source 
of variation in antibody titers at 60 
and 90 days of age, providing further 
evidence for signifi cant variation asso-
ciated with maternal antibodies. Other 
work has shown that high titers of 
maternal PCV2 antibodies are gener-
ally protective against PCV2, whereas 
low titers are not; however, maternal 
antibodies do not fully prevent PCV2 
infections. Thus, pigs in our study 
were likely at least partially protected 
from PCV2 by maternal antibodies to 
at least 60 days of age. 
Implications
Immune responses to PCV2 are 
heritable. Thus, genetic selection could 
be a useful tool to reduce incidence 
of PCVAD. Even though progress is 
permanent, several generations of 
selection will be required to greatly 
reduce the incidence and this selection 
must be practiced in nucleus herds and 
then transmitted through the breeding 
pyramid to commercial populations. 
Consequently, it would take consider-
able time for such a strategy to signifi -
cantly reduce the incidence of PCVAD 
in commercial herds. Furthermore, 
response to selection for PCVAD 
scores, viremia, and antibody levels 
will occur only if all pigs in nucleus 
populations are exposed to PCV2 so 
that variation refl ects genetic varia-
tion in the traits. Marker assisted or 
genomic selection may be more effec-
tive as once marker panels with known 
relationships with response variables 
are available, selection can be practiced 
in any population without exposure of 
pigs to PCV2. Thus genomic selection 
for resistance to PCV2 and decreased 
incidence of PCVAD may be the most 
effective long term selection strategy.
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